Illumina exhibits better profitability ratios than many of its peers, which indicates that the company could continue to invest in its operations. In Q3 2025, ILMN raised its EPS to $4.65-$4.75, ...
Illumina Inc. (NASDAQ:ILMN) is one of the 8 Best Quality Stocks to Buy According to Hedge Funds. Illumina Inc. (NASDAQ:ILMN) is one of the best quality stocks to buy according to hedge funds. On March ...
Illumina and the Center for Data-Driven Discovery in Biomedicine launched a large pediatric genomic data initiative focused on rare diseases and cancer. The collaboration will analyze 100,000 whole ...
Illumina fundamentals are improving, with FY26 expected to return to positive growth and enable operating leverage. Find out ...
San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech company at ...
China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US tariffs on all Chinese goods, deepening the US company’s woes in one of its ...
Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology ...
San Diego’s Illumina is the world leader in gene sequencing technology — the ability to read and record DNA. Now, the billion-dollar company is buying another in a bid to expand its portfolio in ...
SAN DIEGO, Feb. 3, 2026 — Illumina (NASDAQ: ILMN) today announced a sequencing agreement with the San Diego Zoo Wildlife Alliance (SDZWA)’s Frozen Zoo®. The 50-year-old biobank is the world’s most ...
What if the biggest winners in biotech weren’t the ones promising miracle cures, but the ones quietly supplying the picks and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results